Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study

Jan 18

Written By Squarespace Specialist

Squarespace Specialist

OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo- controlled trial in adult females

Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial